CLINICAL_TRIALS trial_result · 2009-06-11

Clinical Trial Update: Remicade® Crohn's Disease Registry Across Canada (Study P02793)

Terminated Canadian Crohn's disease registry trial of Remicade (infliximab) is reported. Results were posted in 2009.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Merck Sharp & Dohme LLC | Conditions: Crohn's Disease | Status: TERMINATED | Results posted: 2009-06-11